Internal Medicine, Cardiovascular Disease · South Miami, FL
NPI
1164412276
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
6200 Sunset Dr, Suite 401
South Miami, FL, 33143
Phone (305) 666-4633
Groups this clinician bills Medicare through
Medicare paid, 2024
$262K
2,753 services
Medicare patients, 2024
531
Average age 77
Drug cost, 2024
$2.2M
14,571 prescriptions
Company payments, 2025
$578
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Orlando V Almanza was code 99213 (office e&m - established), 733 times for 350 patients. In total Orlando V Almanza billed 2,753 services in 42 codes, and Medicare paid $262K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 733 | 350 | $64.24 | $47K |
| 99457 E&M - Miscellaneous | Office | 324 | 36 | $36.89 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 311 | 220 | $13.40 | $4,166 |
| 93000 Electrocardiogram | Office | 235 | 187 | $10.63 | $2,497 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 192 | 47 | $5.32 | $1,021 |
| 99454 E&M - Miscellaneous | Office | 171 | 32 | $36.44 | $6,231 |
| 99458 E&M - Miscellaneous | Office | 124 | 30 | $31.19 | $3,868 |
| 93010 Electrocardiogram | Facility | 116 | 105 | $6.68 | $775 |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 88 | 44 | $312.86 | $28K |
| 93306 Echocardiography (TTE/TEE) | Office | 87 | 85 | $146.05 | $13K |
| 99204 Office E&M - New | Office | 65 | 65 | $122.90 | $7,989 |
| 93015 Electrocardiogram | Office | 57 | 56 | $56.02 | $3,193 |
| 78434 Myocardial Perfusion Scan | Office | 44 | 44 | $502.17 | $22K |
| 78431 Myocardial Perfusion Scan | Office | 44 | 44 | $1,910.03 | $84K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 24 | 12 | $351.48 | $8,435 |
By year: 2022 $191K for 4,481 services; 2023 $202K for 3,190 services; 2024 $262K for 2,753 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 25 | 21 | $5.88 | $147 |
Medicare prescription drug claims, 2024
In 2024, the drug Orlando V Almanza prescribed most often to Medicare patients was Metoprolol Succinate, with 1,039 prescriptions and refills. In total Orlando V Almanza wrote 14,571 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,039 | 2,945 | 322 | $12K |
| Amlodipine Besylate Generic | 967 | 2,668 | 301 | $5,368 |
| Atorvastatin Calcium Generic | 949 | 2,671 | 317 | $8,441 |
| Losartan Potassium Generic | 759 | 2,066 | 244 | $7,776 |
| Hydrochlorothiazide Generic | 656 | 1,684 | 216 | $3,604 |
| Eliquis Apixaban | 633 | 1,253 | 173 | $730K |
| Hydralazine Hcl Generic | 604 | 1,615 | 202 | $6,609 |
| Lisinopril Generic | 509 | 1,442 | 166 | $3,205 |
| Carvedilol Generic | 498 | 1,322 | 161 | $3,919 |
| Isosorbide Dinitrate Generic | 450 | 1,154 | 133 | $25K |
| Clopidogrel Clopidogrel Bisulfate | 396 | 1,057 | 124 | $2,939 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 369 | 1,004 | 134 | $4,773 |
| Rosuvastatin Calcium Generic | 367 | 983 | 130 | $4,442 |
| Metoprolol Tartrate Generic | 336 | 897 | 102 | $1,963 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 264 | 678 | 86 | $8,477 |
Brand drugs: 1,810 claims; generic drugs: 12,761 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Orlando V Almanza $578 ($578 in general payments such as food, travel and fees) from 12 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $100.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $100 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $96.92 |
| Pfizer Inc. PFE | 6 | $95.99 |
| Abbott Laboratories ABT | 1 | $53.85 |
| Scpharmaceuticals Inc. SCPH | 1 | $36.27 |
| Boston Scientific Corporation BSX | 1 | $34.39 |
| Novo Nordisk Inc NVO | 2 | $32.61 |
| Kestra Medical Technology Services, Inc. | 2 | $31.53 |
| United Therapeutics Corporation UTHR | 1 | $28.7 |
| Edwards Lifesciences Corporation EW | 1 | $28.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.